3D Printing applications in cardiovascular medicine JK Min, B Mosadegh, S Dunham, SJ Al'Aref Academic Press, 2018 | 61 | 2018 |
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies R Hachem, A Assaf, Y Numan, P Shah, Y Jiang, AM Chaftari, II Raad International journal of antimicrobial agents 50 (3), 384-388, 2017 | 41 | 2017 |
First report of clinical response to venetoclax in early T-cell precursor acute lymphoblastic leukemia Y Numan, M Alfayez, A Maiti, Y Alvarado, EJ Jabbour, A Ferrajoli, ... JCO precision oncology 2, 2018 | 33 | 2018 |
Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome … X Li, CA Arias, SL Aitken, J Galloway Peña, D Panesso, M Chang, L Diaz, ... Clinical Infectious Diseases 67 (3), 398-406, 2018 | 29 | 2018 |
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors Y Numan, Z Abdel Rahman, J Grenet, S Boisclair, JP Bewersdorf, ... American journal of hematology 97 (3), 322-328, 2022 | 28 | 2022 |
A novel nonantibiotic nitroglycerin-based catheter lock solution for prevention of intraluminal central venous catheter infections in cancer patients AM Chaftari, R Hachem, A Szvalb, M Taremi, B Granwehr, GM Viola, ... Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00091-17, 2017 | 26 | 2017 |
Comparison of transradial and transfemoral approaches for coronary angiography and percutaneous intervention in patients with coronary bypass grafts H Hirzallah, A Amro, D Kusmic, Z Curtis, EC Leigh, Y Numan, J Parsons, ... Cardiovascular Revascularization Medicine 21 (1), 2-5, 2020 | 16 | 2020 |
Comparing outcomes between liposomal daunorubicin/cytarabine (cpx-351) and hma+ venetoclax as frontline therapy in acute myeloid leukemia J Grenet, AG Jain, M Burkart, J Waksal, C Famulare, Y Numan, M Stahl, ... Blood 138, 32, 2021 | 15 | 2021 |
Ammonia vs. lactic acid in predicting positivity of microbial culture in sepsis: the ALPS pilot study Y Numan, Y Jawaid, H Hirzallah, D Kusmic, M Megri, O Aqtash, A Amro, ... Journal of Clinical Medicine 7 (8), 182, 2018 | 10 | 2018 |
Candida krusei empyema thoracis: a community-acquired infection requiring a high index of suspicion H Bukamur, W Ahmed, Y Numan, I Shahoub, F Zeid Case Reports in Infectious Diseases 2018, 2018 | 5 | 2018 |
Innate immune mechanisms and immunotherapy of myeloid Malignancies S Small, Y Numan, LC Platanias Biomedicines 9 (11), 1631, 2021 | 4 | 2021 |
Invasive Staphylococcus Epidermidis Isolates are Highly Clonal and Distinct from Commensal Strains: Time for a New Paradigm in Infection Control? RW Dib, Y Numan, X Li, A Kalia, I Raad, SA Shelburne Open Forum Infectious Diseases 4 (suppl_1), S564-S564, 2017 | 4 | 2017 |
Genetically Informed Prostate Cancer Treatment for Metastatic Disease. AL Siebert, BM Szymaniak, Y Numan, AK Morgans The Urologic Clinics of North America 48 (3), 365-371, 2021 | 2 | 2021 |
Gilteritinib Remains Clinically Active in Relapsed/Refractory FLT3 Mutated AML Previously Treated with FLT3 inhibitors Blood 136 (Supplement 1), 5-7, 2020 | 2 | 2020 |
Correction for Chaftari et al.,“a novel nonantibiotic nitroglycerin-based catheter lock solution for prevention of intraluminal central venous catheter infections in cancer … AM Chaftari, R Hachem, A Szvalb, M Taremi, B Granwehr, GM Viola, ... Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 01324-17, 2017 | 2 | 2017 |
Advances in the pharmacological management of acute myeloid leukemia in adults Y Numan, Y Abaza, JK Altman, LC Platanias Expert opinion on pharmacotherapy 23 (13), 1535-1543, 2022 | 1 | 2022 |
Outcomes and predictors of relapse with use of hypomethylating agents in combination with venetoclax prior to allogeneic transplant in acute myeloid leukemia I Nizamuddin, TS Oh, Y Numan, MF Kelsten, M Burkart, O Frankfurt, ... Blood 138, 2327, 2021 | 1 | 2021 |
Myeloid sarcoma reveals a unique tumor micro-environment and differential prognosis based on transplant status and type of treatment received Y Numan, H Tariq, J Fan, P Xie, M Burkart, Y Abaza, YH Chen, S Dinner, ... Blood 138, 3432, 2021 | 1 | 2021 |
Chemokine signaling and MAPK/ERK pathway for advanced prostate cancer treatment response. Y Numan, J Zhao, S Tang, Y Zhang, Q Zhang, B Jovanovic, ... Journal of Clinical Oncology 38 (6_suppl), TPS275-TPS275, 2020 | 1 | 2020 |
100.45 Transradial Versus Transfemoral Access for Coronary Angiography and Intervention in Patients With Previous History of Coronary Artery Bypass Surgery A Amro, H Hirzallah, E Leigh, Z Curtis, M Amro, O Aqtash, Y Numan, ... JACC: Cardiovascular Interventions 12 (4S), S14-S14, 2019 | 1 | 2019 |